Based on our evaluation of the five key dimensions—Technical Signals, Moving Average trends, Short Sell Data, Similar Chart Pattern Matching and Seasonality Analysis—we have identified the following insights. ABT has several positive signals and is within a rising trend, so we believe it will perform strongly in the next couple of days or weeks. We therefore hold a positive evaluation of this stock. Our analysis conclusion for this stock is a Strong Buy candidate.
ABT stock price ended at $132.41 on Wednesday, after rising0.1%
The Abbott Laboratories stock price increased by 0.1% on the last trading day (18 Jun 2025), rising from 132.95 to 132.41. Throughout the last trading session, the stock experienced a fluctuation of 1.34% , ranging from a day low of $131.6 to a day high of 133.37. The price has declined in 5 of the last 10 days, resulting in a total change of -0.41% during this period. On the last day, trading volume increase by -60.09K shares, with the rising prices. This could serve as an early warning, indicating that risk may slightly increase in the coming days. In total, 4.95M shares were traded, amounting to approximately 655.89M.
ABT Technical Signals
ABT(Abbott Laboratories Corp) has 3 buy signals and 1 sell signal now. The current trend is consolidation starting from 2025-06-13. The total price change during this trend is -2.37%. Recently, the price has increased but the volume has decreased, indicating a potential warning signal. The average turnover of ABT over the last 5 trading days is 645.24M. Overall, the technical indicator signals lean more toward a Bullish outlook in the mid-term.
ABT Moving Average Analysis
Abbott Laboratories's overall moving average trend leans more bullish as of Friday, June 20, 2025, with 1 negative signals and 3 positive signal. In the mid-term, the SMA_20 being above the SMA_60 signals a strong bullish trend. There will be some resistance from the lines at $137.85156333333333, and $140.23333333333335. A break-up above any of these levels will issue buy signals. There will be some support from the lines at $130.14510333333334, and $127.76333333333332. A break-down below any of these levels will issue sell signals.
ABT Short Selling Analysis
The short sale ratio of Abbott Laboratories(ABT) as of 17 Jun 2025 is 14.40%, dropping from last trading day. With decreasing price from 134.01 to 132.28. The short sell activity indicate that short sellers may be anticipating price hit a bottom.
Technical Signal
Technical Signals Summary
Sell
1
Buy
3
Moving Average
Swing
Negative
Stock Price Below SMA_5
Short Term
Positive
SMA_5 Above SMA_20
Mid Term
Positive
SMA_20 Above SMA_60
Long Term
Positive
SMA_60 Above SMA_200
Short Selling
Close Price
Short Sale Ratio
Short Sale Volume
3 Bullish Signals
3 Bullish Signals
When Value satisfies Signal, Indicator signals Bullish
Indicators
Signal
Value
Meaning
Awesome Oscillator (5, 34)
AO_5_34 > 0
1.44
Bullish
Moving Average Convergence Divergence (12, 26, 9)
MACD_12_26_9 > 0
0.48
Bullish
Stochastic RSI %K (14, 14, 3, 3)
STOCHRSIk_14_14_3_3 < 20
6.153
Bullish
1 Bearish Signals
1 Bearish Signals
When Value satisfies Signal, Indicator signals Bearish
Indicators
Signal
Value
Meaning
Momentum (10 days)
MOM_10 < 0
-0.55
Bearish
ABT Price Prediction & Forecast by Similar Chart Analysis
Based on historical patterns and backtesting of stocks with similar movements to Abbott Laboratories(ABT), our algorithm predicts ABT's 1-month price at $132.09, with an -2.6%downwardshift. Using a similarity score up to 90.38%and other factors, This forecast updates weekly, adjusting for significant deviations.
Similar Chart
The price prediction chart for Abbott Laboratories (ABT.N) stock, as of Sunday, June 15, 2025 , forecasts a -2.6% change over the next month, based on its high correlation with CNP.N stock patterns. The similarity between their price movements over the analyzed periods is 90.38%. The right panel lists other stocks with similar price patterns. This prediction is updated every week.
ABT
No Data
CNP
Down: -2.6%Similarity: 90.38%
Name
Similarity
Up/Down
CNP.N
90.38%
-2.60%
ABT Seasonality Analysis
Based on ABT's historical stock price data across all years, the probability of a positive return in June is66.67%, suggesting it maybe an ideal month to invest in ABT. In contrast,Novemberoffers the highest probability of positive returns at75.00%, making it a potentially strong month for investment.
However, this is only a prediction based on one method, and a comprehensive assessment of the stock's future trend should consider additional factors. Our final stock price commentary incorporates three main evaluation dimensions: technical signals, Moving Average trends, and similar chart pattern matching, with the first two dimensions carrying the primary weight to ensure a more robust and accurate forecast.
Monthly Seasonality
The radar chart shows that buying Abbott Laboratories (ABT.N) stock in November has the highest probability of a positive return (75.00%), while March has the lowest probability (30.77%).
Performance Seasonality
The chart shows Abbott Laboratories. (ABT)'s annual stock price return for the past three years, helping you analyze price trends and identify recurring trends on an annual basis.
People Also Watch
FAQ
Should I buy Abbott Laboratories (ABT.N) stock?
Based on our evaluation of the five key dimensions—Technical Signals, Moving Average trends, Short Sell Data, Similar Chart Pattern Matching and Seasonality Analysis—we have identified the following insights. ABT has several positive signals and is within a rising trend, so we believe it will perform strongly in the next couple of days or weeks. We therefore hold a positive evaluation of this stock. Our analysis conclusion for this stock is a Strong Buy candidate.
Which months have the highest win rate for buying Abbott Laboratories (ABT.N) stock in a year?
The radar chart shows that buying Abbott Laboratories (ABT.N) stock in November has the highest probability of a positive return (75.00%), while March has the lowest probability (30.77%).
How has Abbott Laboratories. (ABT)'s stock price performed over the past three years?
ABT's stock price rose by 0.45% in 2023,increased by 2.97% in 2024, and went up by 16.72% in 2025.
Bearish technical signals of ABT include: MOM_10 < 0.
Is ABT a buy based on overall technical signals summary?
ABT has 3 buy signals and 1 sell signals now. Overall the technical rating for ABT is Buy . Note that market conditions change all the time. In addition to technical ratings, keep an eye on the Valuation Level of ABT.
What is the trend of Abbott Laboratories (ABT)'s moving average?
Abbott Laboratories's overall moving average trend leans more bullish as of June 20 2025, with 1 negative signals and 3 positive signal.
What is price prediction for ABT stock next month?
The price prediction chart for Abbott Laboratories (ABT.N) stock, as of June 15 2025, forecasts a -2.6% change over the next month, based on its high correlation with CNP stock patterns. The similarity between their price movements over the analyzed periods is 90.38%. The right panel lists other stocks with similar price patterns. This prediction is updated every week.
What is price prediction 2025 for ABT Stock?
The price prediction for ABT stock in 2025 is expected to reach **$138-$140**. This forecast is based on stable earnings growth, a strong dividend yield of 1.74%, and positive analyst sentiment with a consensus price target of $137.12-$140.57.
What is price prediction 2030 for ABT Stock?
### **Price Prediction for Abbott Laboratories (ABT) Stock by 2030**
Based on current trends, financial performance, and market expectations, Abbott Laboratories (ABT) is expected to reach a stock price of **$160 to $180 by 2030**.
- **Strong Fundamentals**: Abbott has a diversified healthcare portfolio with consistent revenue growth and a history of strong earnings performance.
- **Innovation and Growth**: Recent collaborations, such as the integration of Abbott's dual glucose-ketone sensor with Tandem Diabetes Care, highlight its commitment to innovation and market expansion.
- **Valuation**: The stock is reasonably valued with a forward P/E of 25.44 and a P/S ratio of 5.12, leaving room for long-term growth.
- **Analyst Sentiment**: A "Strong Buy" consensus rating with a price target of $140.57 suggests confidence in its near-term growth.
This prediction assumes continued execution of its business strategy and stable market conditions.